Patents by Inventor Shawn D. Keil

Shawn D. Keil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Induction of and Maintenance of Nucleic Acid Damage in Pathogens Using Riboflavin and Light
    Publication number: 20110236876
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Application
    Filed: June 8, 2011
    Publication date: September 29, 2011
    Applicant: CARIDIANBCT BIOTECHNOLOGIES, LLC
    Inventors: Robert Owen LOCKERBIE, Vijay KUMAR, Shawn D. KEIL, Raymond P. GOODRICH
  • Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
    Patent number: 8017110
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: September 13, 2011
    Assignee: CaridianBCT Biotechnologies, LLC
    Inventors: Raymond P. Goodrich, Shawn D. Keil, Robert Owen Lockerbie, Vijay Kumar
  • Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
    Patent number: 7985588
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: July 26, 2011
    Assignee: CaridianBCT Biotechnologies, LLC
    Inventors: Raymond P. Goodrich, Shawn D. Keil
  • Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
    Patent number: 7901673
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Grant
    Filed: August 25, 2003
    Date of Patent: March 8, 2011
    Assignee: CaridianBCT Biotechnologies, LLC
    Inventors: Robert Owen Lockerbie, Vijay Kumar, Shawn D. Keil, Raymond P. Goodrich
  • Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
    Publication number: 20040081956
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Application
    Filed: August 25, 2003
    Publication date: April 29, 2004
    Applicant: Gambro, Inc.
    Inventors: Robert Owen Lockerbie, Vijay Kumar, Shawn D. Keil, Raymond P. Goodrich